Skip to main content

Trending

  • COVID-19
  • Biden's inauguration
  • Trump impeachment

Social Media Menu

  • Facebook
  • Instagram
  • Tumblr
  • Twitter
  • YouTube

Utility Navigation

  • Take Action
  • Search
  • Donate

Media Matters for America

Main navigation

  • News & Analysis
  • Research & Studies
  • Audio & Video
  • Archives

Media Matters for America

  • Nav
  • Search

Main navigation

  • News & Analysis
  • Research & Studies
  • Audio & Video
  • Archives

Trending

  • COVID-19
  • Biden's inauguration
  • Trump impeachment

Utility Navigation

  • Take Action
  • Search
  • Donate

Social Media Menu

  • Facebook
  • Instagram
  • Tumblr
  • Twitter
  • YouTube
Plasma MSM
Molly Butler / Media Matters

Media outlets ignore objections from public health experts on FDA emergency use authorization of convalescent plasma

Written by Madeline Peltz

Published 08/24/20 6:00 PM EDT

Share

  • Email
  • Twitter
  • Facebook
  • Print

Comment

  • Comments

Under pressure from the Trump White House on the eve of the Republican National Convention, the Food and Drug Administration issued an emergency use authorization yesterday for a potential therapeutic against COVID-19. But mainstream news coverage of the announcement largely ignored objections from public health experts that critical data needed to justify this move from the FDA is missing.

During the August 23 press conference announcing the change, both President Donald Trump and FDA Commissioner Stephen Hahn “grossly mischaracterized" what the data actually shows regarding the effectiveness of the new treatment, known as convalescent plasma. The authorization comes a day after the president’s baseless tweet over the weekend targeting Hahn, claiming “the deep state, or whoever, over at the FDA” are delaying therapeutic developments until after the election. This is the second emergency use authorization during the COVID-19 pandemic that has led to experts calling the FDA’s independence into question. The regulatory body granted expanded access to the antimalarial drug hydroxychloroquine following an immense pressure campaign by Trump and Fox News. That emergency use authorization was revoked months later, and the drug's use in treating COVID-19 was relabeled with a safety warning.

Data reflecting the effectiveness of treating COVID-19 patients with blood plasma rich with virus-fighting antibodies from other patients who have recovered from the disease, also called convalescent plasma, is not available due to the lack of randomized, controlled clinical trials. The FDA’s announcement cites an expanded access trial that does not include a placebo group, a necessary component to determine the treatment’s effectiveness. Research published in June from the Mayo Clinic found the treatment to be safe when administered to 20,000 patients, but the study has not been peer-reviewed and also did not have a placebo group. 

The treatment’s new emergency use authorization was delayed by objections from experts, including Dr. Anthony Fauci, and arguably falls short of the FDA’s guidance on emergency use authorizations because of the lack of data on its effectiveness, although the FDA claimed otherwise in its announcement. 

Many mainstream media outlets excluded those concerns from headlines covering the development, and some did not mention objections raised by scientists until well into the article. FoxNews.com’s coverage ignored skepticism from scientists altogether. This is part of a pattern in media headlines, which often repeat misinformation, political spin, and lies that come directly from Trump, leaving out the truth or burying it in the body of the article. Additionally, many of the articles did not explain why randomized controlled clinical trials are considered the “best evidence" in determining a drug’s effectiveness. (These types of trials are not mandated by the FDA in issuing an emergency use authorization, but without them, a critical portion of the data used to control research for bias is entirely missing.)

The New York Times’ headlines, both in its breaking updates coverage as well as the full write-up, did not mention the scientific community’s objections to the new treatment’s authorization.

nyt1
nyt2

The headline from The Associated Press did not mention the objections to the new authorization from medical experts. However, the article did prominently feature Trump’s unfounded claim that the FDA is trying to slow down treatment development to hurt him politically in the article’s second paragraph. It didn't mention the lack of evidence and controlled trials until the fourth and fifth paragraphs.

associated press

The Wall Street Journal’s headline on the FDA announcement excluded the experts’ concerns. The Journal also ran an article on a boost in the stock market based on the development, but did not mention the destabilizing effect created by increased volatility in the markets due to “retail investors” reacting to “headline news” of potential treatments.

wsj1
wsj2

FoxNews.com’s article left objections from experts out of the headline and did not mention the “inconclusive” evidence for the new treatment’s authorization until the seventh paragraph. It also failed to mention the community of scientists concerned about its authorization and the White House’s political pressures on the FDA, nor did it mention the lack of a placebo group or the limitations of making regulatory decisions based on an expanded access trial.

fox

Axios ran a headline that did not mention objections from the scientific community or lack of conclusive data on the treatment’s effectiveness, though both issues were referenced later in the article.

axios

CNN’s headline did not mention concerns the experts had raised about the treatment’s effectiveness. The article did not mention the lack of randomized control trials until the seventh paragraph. Additionally, the section titled “Experts say more data is needed” led not with objections from scientists but with Secretary of Health and Human Services Alex Azar’s comments justifying the emergency use authorization. (Azar is a Trump sycophant and former pharmaceutical lobbyist, not a doctor.) Fauci’s concerns about the treatment were not mentioned until the 18th paragraph.

cnn

NBC News ran a headline without mentioning the inconclusive and lacking evidence. 

nbc news

CBS News’ headline did not mention limited evidence for the FDA authorization or objections by the scientific community. Although the report’s video package mentioned that the “medical research is not clear” on the effectiveness of the treatment, the news came in the context of reporting on White House politics and Trump’s reelection campaign, not scientific research and drug development. In the body of the short article which accompanied the video, the only mention of concerns from scientists was a quote from former FDA Commissioner Scott Gottlieb at the very bottom of the article.

cbs

CNBC ran at least two headlines on the emergency use authorization. One of them didn’t mention concerns about the treatment from scientists and top health officials, although the lede of the article did, while the other article did mention those concerns in the headline. Like other financial outlets, CNBC also ran an article on Monday’s market movements in response to the news that wholly excluded the lack of evidence regarding the treatment’s effectiveness or the role of misleading headlines about “positive developments on coronavirus treatments and vaccines” responsible for creating “bullish sentiment.”

cnbc1
cnbc2
cnbc3

The Latest

  1. Newsmax analyst says Trump's conviction would call into question the legitimacy of the 2024 presidential election

    Video & Audio 01/26/21 10:49 AM EST

  2. After embracing QAnon, Steve Bannon now presents the conspiracy theory as an “FBI psyop”

    Article 01/26/21 10:27 AM EST

  3. On YouTube, The Epoch Times promoted “Stop the Steal” events and spread misinformation before and after Capitol riots

    Article 01/26/21 9:15 AM EST

  4. Laura Ingraham calls attempts to prevent QAnon radicalization in the military "absolutely poisonous”

    Video & Audio 01/25/21 10:58 PM EST

  5. Tucker Carlson defends QAnon

    Video & Audio 01/25/21 8:45 PM EST

Pagination

  • Current page 1
  • …
  • Next page ››

In This Article

  • Coronavirus (COVID-19)

    Covid-19 / Coronavirus
  • The New York Times

    The-New-York-Times-MMFA-Tag.png
  • The Wall Street Journal

    Wall Street Journal
  • NBC

    NBC-MMFA-Tag.png
  • CNBC

    CNBC-MMFA-Tag.png
  • Associated Press

    Associated Press
Comments
0 Comments
Share Count
0 Shares

Related

  1. Several major media outlets failed to quote trans people in reports on repeal of trans military ban

    Article 01/25/21 6:00 PM EST

  2. Fox News ignores a COVID-19 spike to pretend there was no COVID-19 spike

    Article 01/25/21 12:01 PM EST

  3. Conservatives' latest absurd attack on Biden: He's violating calls for “unity” unless he does everything we want

    Article 01/25/21 10:59 AM EST

Media Matters for America

Footer menu

  • About
  • Contact
  • Corrections
  • Submissions
  • Jobs
  • Privacy Policy
  • Terms & Conditions

Social Media Menu

  • Facebook
  • Instagram
  • Tumblr
  • Twitter
  • YouTube

© 2021 Media Matters for America